A Zamboni operator has died following a workplace collision at the Edora Pool Ice Center, prompting a city-wide safety review and temporary closure of the rink.
The death of 17-year-old Caden Nowicki marks the third fatal sledding incident in North Texas in less than a week, raising urgent questions about winter recreation safety.
New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.
Samsara Inc. is emerging as the operational backbone for major food and beverage companies, driving tangible safety and efficiency gains. Yet, its stock appears undervalued against this growing strategic relevance in critical supply chains.
Facing softer demand and tariff volatility, Minerals Technologies (MTX) reported steady 2025 sales of $2.1B but saw margins contract. Leadership emphasized cost discipline and safety while detailing a series of expansion projects poised to drive a meaningful rebound in the coming year.
Axon Enterprise prepares to report Q4 earnings under intense scrutiny, with its high-flying stock under pressure and a major AI acquisition hanging in the balance. Can its public safety tech expansion justify the premium?
Yong Rong (HK) Asset Management has placed a concentrated bet on online brokerage Webull Corporation, making it the fund's largest U.S. equity holding and signaling confidence in the platform's long-term prospects amid a challenging market.
Following a strategic adjustment to its share capital structure, China's leading online recruitment platform Kanzhun Limited sees sustained bullish sentiment from Wall Street, with a majority of analysts maintaining Buy ratings and forecasting significant upside.
New York Governor Kathy Hochul has proposed legislation to prohibit state and local law enforcement from collaborating with federal immigration authorities, a move the Department of Homeland Security warns will compromise public safety.
BHP Group achieves a key milestone with full autonomy at its Escondida Norte copper pit, boosting safety and efficiency for its strategic copper expansion. Meanwhile, the miner contends with the commercial impact of China's ongoing ban on iron ore from its Jimblebar operation, forcing a reshuffle of global sales channels.
A pivotal week in business saw Tesla's long-awaited robotaxis begin operations without safety drivers, signaling a new phase in autonomous mobility. Meanwhile, Greg Abel's early moves at Berkshire Hathaway hint at a potential strategic shift, and a push for tokenized, round-the-clock stock trading raises questions about the future of finance.
Shares of Corcept Therapeutics plunged 16% after a corrected FDA letter disclosed the agency had repeatedly cautioned the company against filing its application for a Cushing's syndrome drug, which was later rejected over efficacy and safety concerns.
The automotive safety giant posted historic sales and cash flow in 2025, powered by explosive growth with Chinese automakers and in India. While navigating a softer production forecast and tariff headwinds, management projects margin expansion for 2026.
In a fiery address to the U.S. Conference of Mayors, Minneapolis Mayor Jacob Frey called on local leaders nationwide to resist what he described as aggressive federal immigration enforcement, arguing such operations undermine public safety and constitutional rights.
Analysts at Stifel have initiated coverage on sports data giant Sportradar Group AG (NASDAQ: SRAD) with a Buy rating and a $28 price target, citing its dominant market position and favorable industry dynamics as online sports betting consolidates.
Analyst firm Stifel has initiated coverage on sports data giant Genius Sports with a Hold rating, praising its foundational role in the online betting ecosystem but flagging a balanced risk-reward at current levels.
As Baidu pivots from its search engine roots, its heavy investments in autonomous vehicle technology are beginning to yield operational results, reshaping analyst views and sparking fresh valuation discussions amidst fierce AI competition.
Following the FDA's decision to remove the clinical hold on Intellia's Nex-Z hATTR-PN trial, analysts at Baird and H.C. Wainwright have significantly raised their price targets for the CRISPR gene-editing pioneer, citing reduced regulatory risk and a clearer path forward.
Clear Street downgrades Janux Therapeutics (JANX) to Hold, slashing its price target amid concerns over a lack of durability data for its lead candidate JANX007 and rising competitive pressures, despite a recent major collaboration deal with Bristol Myers Squibb.
First Pacific Advisors' FPA Crescent Fund disclosed it sold its position in tech giant Microsoft in Q4 2025. The value-focused fund explained the move was driven by a search for greater upside in other AI-related investments, despite acknowledging Microsoft's strong fundamentals.
